Summary: Aetna modified CPB 0011, its coverage policy for electrical stimulation for pain, with an effective date of April 17, 2026. Here's what billing teams need to do.
Aetna, a CVS Health company, updated CPB 0011 governing electrical stimulation for pain management. The policy does not list specific CPT or HCPCS codes in the data available at this time — more on that below. If your practice bills for TENS, NMES, or spinal cord stimulation under Aetna plans, this change deserves your attention before April 17, 2026.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna |
| Policy | Electrical Stimulation for Pain — CPB 0011 |
| Policy Code | CPB 0011 |
| Change Type | Modified |
| Effective Date | 2026-04-17 |
| Impact Level | High |
| Specialties Affected | Pain management, neurology, physical medicine & rehabilitation, orthopedics, neurosurgery |
| Key Action | Pull your Aetna electrical stimulation claims, audit against updated medical necessity criteria, and verify prior authorization requirements before April 17, 2026 |
Aetna Electrical Stimulation for Pain Coverage Criteria and Medical Necessity Requirements 2026
CPB 0011 is Aetna's clinical policy bulletin governing coverage of electrical stimulation devices and procedures used for pain management. This coverage policy covers a wide range of technologies — from transcutaneous electrical nerve stimulation (TENS) units to spinal cord stimulators (SCS) to peripheral nerve stimulators. Each category carries its own medical necessity threshold, and Aetna draws hard lines between what it covers and what it considers experimental or investigational.
Aetna electrical stimulation coverage policy has historically required documented failure of conservative treatments before approving more invasive or costly modalities. That pattern almost certainly continues here. Medical necessity documentation is the linchpin for this policy — without it, you're looking at a claim denial regardless of how well the procedure was performed.
Because the updated policy document does not include specific CPT or HCPCS codes in the data currently available, your billing team should pull the full CPB 0011 text directly from Aetna's clinical policy library. The full text will contain the definitive list of covered and non-covered codes, and that list drives your charge capture decisions.
What CPB 0011 Historically Covers
Aetna's prior versions of CPB 0011 covered these categories when medical necessity criteria were met:
| # | Covered Indication |
|---|---|
| 1 | TENS (Transcutaneous Electrical Nerve Stimulation): Covered for certain chronic pain conditions after documented failure of other treatments. Rental and purchase of home units have different coverage thresholds. |
| 2 | Neuromuscular Electrical Stimulation (NMES): Covered in specific clinical contexts, particularly post-surgical rehabilitation and disuse atrophy. |
| 3 | Spinal Cord Stimulation (SCS): Covered for conditions like failed back surgery syndrome and complex regional pain syndrome (CRPS), with strict prior authorization requirements and trial stimulation documentation. |
| 4 | Peripheral Nerve Stimulation: Covered in some clinical scenarios, though with narrower criteria than SCS. |
Whether the April 17, 2026 modification expands, restricts, or clarifies these categories is the critical question. Until you review the full updated policy text, treat any Aetna electrical stimulation billing as potentially affected.
Prior Authorization Under CPB 0011
Prior authorization has always been a significant piece of this policy. Spinal cord stimulators, in particular, require prior auth — and that prior auth typically includes documentation of a successful trial stimulation period before permanent implant approval.
Check whether the updated CPB 0011 changes the prior authorization thresholds for any category. If Aetna has tightened criteria for the trial period or added new documentation requirements, your surgery schedulers and PA coordinators need to know before April 17, 2026.
Aetna Electrical Stimulation for Pain Exclusions and Non-Covered Indications
Aetna's CPB 0011 has historically excluded a substantial list of electrical stimulation applications. These exclusions drive a high volume of claim denials for billing teams that don't audit against the policy regularly.
Commonly excluded or experimental designations under prior versions of CPB 0011 include:
| # | Excluded Procedure |
|---|---|
| 1 | Transcranial magnetic stimulation (TMS) for pain — generally considered experimental for pain indications (though covered separately for depression under different policies) |
| 2 | High-frequency spinal cord stimulation — coverage status has been evolving, and this is worth checking against the April 2026 update specifically |
| 3 | Dorsal root ganglion (DRG) stimulation — has carried experimental/investigational status in prior versions |
| 4 | Scrambler therapy (Calmare therapy) — not covered |
| 5 | H-Wave stimulation — not covered |
| 6 | Interferential current stimulation — not covered for most indications |
| 7 | TENS for acute post-operative pain — limited coverage, often excluded beyond the initial hospital stay |
| 8 | Electrical stimulation for headache, migraine, or visceral pain — typically excluded |
These exclusions matter because patients often present with conditions that seem like reasonable candidates for stimulation, and physicians order accordingly. Your job is to catch the mismatch between what's ordered and what's covered before the claim goes out.
If the April 17, 2026 update moves any of these from experimental to covered — or vice versa — that changes your billing posture immediately. Review the full policy text to identify any status changes.
Coverage Indications at a Glance
Because the policy data available does not include specific code-level or indication-level details from the updated CPB 0011, this table reflects the historical framework. Verify each row against the April 17, 2026 policy text before relying on it for billing decisions.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| TENS for chronic low back pain | Covered (with criteria) | Verify in updated CPB 0011 | Requires documented failure of conservative treatment |
| TENS for acute post-operative pain (home use) | Limited / Not Covered | Verify in updated CPB 0011 | Often excluded beyond hospital discharge |
| NMES for disuse atrophy post-surgery | Covered (with criteria) | Verify in updated CPB 0011 | Clinical documentation of atrophy required |
| Spinal cord stimulation (SCS) for failed back surgery syndrome | Covered (with criteria) | Verify in updated CPB 0011 | Prior auth required; trial stimulation period required |
| Spinal cord stimulation for CRPS | Covered (with criteria) | Verify in updated CPB 0011 | Prior auth required; multidisciplinary evaluation typically required |
| High-frequency SCS (e.g., 10 kHz) | Evolving — check April 2026 update | Verify in updated CPB 0011 | Status may have changed in this modification |
| Dorsal root ganglion (DRG) stimulation | Experimental / Not Covered (historically) | Verify in updated CPB 0011 | Confirm whether April 2026 update changed this |
| Peripheral nerve stimulation | Limited — covered for select indications | Verify in updated CPB 0011 | Criteria vary by site and condition |
| Scrambler therapy / Calmare therapy | Not Covered | Verify in updated CPB 0011 | Experimental designation |
| H-Wave stimulation | Not Covered | Verify in updated CPB 0011 | Experimental designation |
| Transcranial magnetic stimulation for pain | Not Covered | Verify in updated CPB 0011 | See separate TMS policy for depression |
| Interferential current stimulation | Not Covered | Verify in updated CPB 0011 | Experimental designation |
Aetna Electrical Stimulation for Pain Billing Guidelines and Action Items 2026
This is a high-exposure policy. Pain management and spine practices bill electrical stimulation at significant volume, and CPB 0011 touches everything from inexpensive TENS rentals to five-figure spinal cord stimulator implants. One criteria shift can flip dozens of claims from paid to denied.
Here are your action items before April 17, 2026:
| # | Action Item |
|---|---|
| 1 | Pull the full CPB 0011 policy text from Aetna's website now. The effective date is April 17, 2026. You need the side-by-side comparison of old and new criteria to know exactly what changed. Don't wait for a denial to discover the difference. |
| 2 | Identify every active prior authorization for electrical stimulation procedures. Any PA submitted before April 17, 2026 under old criteria may not hold if the criteria tighten. Call Aetna to confirm whether in-flight prior authorizations remain valid after the effective date. |
| 3 | Audit your charge capture for electrical stimulation billing. Until the updated CPB 0011 lists specific CPT and HCPCS codes, use the historical code set as your baseline. Your billing team should flag any electrical stimulation claims submitted on or after April 17, 2026 for manual review against the updated policy. |
| 4 | Update your medical necessity documentation templates. If the April 2026 update adds or changes documentation requirements — conservative treatment failure, specific diagnosis codes, trial period criteria — your clinical staff needs updated intake and documentation workflows before that effective date. |
| 5 | Check reimbursement rates for any newly covered or newly excluded codes. If Aetna moved a technology from experimental to covered, your fee schedule negotiations and charge capture should reflect that. If a previously covered code moved to experimental, pull any pending claims before they go out. |
| 6 | Brief your spinal cord stimulator coordinators on prior auth changes. SCS prior authorization is the highest-dollar exposure in this policy. If Aetna changed trial stimulation duration requirements or added new documentation criteria, those changes hit your surgical scheduling pipeline immediately. |
| 7 | Loop in your compliance officer if your practice is a high-volume Aetna electrical stimulation biller. CPB 0011 modifications at this level — especially if they affect spinal cord stimulation coverage — can create retroactive audit exposure. Your compliance officer should know the effective date and what changed. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Electrical Stimulation for Pain Under CPB 0011
The policy data provided for this update does not include specific CPT, HCPCS, or ICD-10 codes. The updated CPB 0011 policy document is the authoritative source for the full code list.
Do not rely on historical code sets without verifying against the April 17, 2026 policy text. Aetna's coverage policies frequently update covered code lists alongside criteria changes, and the two move together.
To get the current, verified code list for electrical stimulation billing under CPB 0011:
- Visit Aetna's clinical policy bulletin library at aetna.com and search for CPB 0011
- Review the "Applicable CPT/HCPCS Procedure Codes" section of the updated bulletin
- Cross-reference covered codes against your current charge master
Common code categories historically associated with CPB 0011 include HCPCS codes for TENS unit rental and purchase, CPT codes for spinal cord stimulator trial and implant procedures, CPT codes for peripheral nerve stimulator placement, and related E&M and pain management CPT codes. But you need the actual codes from the April 2026 update — not assumptions based on prior versions.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.